Moreover, Guanabenz (GBZ), an inhibitor of GADD34 (a phosphatase that carries out eIF2α dephosphorylation), showed protection against stress-induced dopamine neurodegeneration in various PD models by enhancement of ATF4 and Parkin expression [116]. This evidence concerns the gene PRKN and Parkinson disease.